Professional Documents
Culture Documents
an oral glutamine
Tomas
bicarbonate
load13
and growth
tamine,
An oral
subjects
Two
and
grams
ingested
Forearm
and
at 30-mm
circulating
glutamine
over a 20-mm
venous
blood
intervals
and
mm.
60
Ninety
mm
period
samples
minutes
and
capable
hormone.
that
the
concen-
increase
plasma
growth
Subjects
and
methods
with
time
responded
glutamine
value
load
plasma
findings
glutamine
load
as plasma
is
growth
WORDS
growth
hormone
Glutamine
load, plasma
healthy
lected
plasma
secretion
rates
performed
on
same
time,
3.8,
Glutamine
ance between
blood stream
with
dietary
that
glutamine
However,
homeostasis
reflects
the minute-to-minute
balglutamine
removal
from and addition
to the
(1). Normally,
endogenous
production
combined
intake
suffice
physiological
an acid
load,
may
for
the
daily
challenges,
small
Beside
(1),
role
its unique
glutamine
intestine
(3).
organ
function
dependent
processes
matory
fact,
it is not
response
such
(6)
over-training
plasma
glutamine
siveness
as judged
perspective
an oral
cial in anticipation
could be generated.
1058
plasma
both
glutamine
under
on glutamine.
with
immune
system
to infection
(7).
supplement
might
prove
and
capable
glutamate
of
growth
Am
as well
as
the
third
decade
1) were segrowth
hor-
(10,11).
Saturdays
Studies
at exactly
the
a light breakfast
(toast,
to ensure
a low basal
growth
an initial forearm
venous
blood
(490 mL carbonated
soft drink,
20 g glucose)
or vehicle
Louis)
was
ingested
over
St
60,
present
samples
and
90
protocol
Medical
was
(2
mm.
mL)
The
approved
College
Human
Research.
Blood samples
plus
2 g
a 20-mm
drawn
at
amount
30-mm
of glutamine
were
placed
Review
Juan
Capistrano,
was
bicarbonate
drawn
(Nichols
by
State
Board
10 mm at 4 #{176}C),
and plasma
hormone
by radioimmunoassay
CA),
by the Louisiana
Institutional
g for
growth
for
(10 000 x
for analysis
Institute,
of
San
microgasometry,
and
glutamine
by HPLC as described
previously
(13). All analyses
were
performed
the same
day. Precision
for determining
plasma glutamine
was 3%, for total carbon
dioxide
1.5%
(95%
representing
bicarbonate),
Intrassay
5%.
growth
determined
growth
and
hormone
for
growth
variability
to be 7.8
2.8%.
hormone
is 0.06
The
hormone
for five
sensitivity
g/L,
this
From
the Department
of Physiology,
subjects
in detecting
allowing
Louisiana
lege of Medicine,
Shreveport,
LA.
2 Supported
by funding
from Research
Louisiana
benefi-
3 Address
Louisiana
LA
amino
hormone
J C/in Nutr
to
for
measure-
In
responFrom
The
University
depressed
concentrations,
eliciting
(12).
plasma
antiinflam-
reserves
y (Table
in human
32-64
consecutive
blood
30,
was
consumed
ranged from 0.016 to 0.036 g/kg (Table 1). Note that
subject A consumed
20 times this amount (0.56 g/kg) during an
identical
protocol
in an earlier study without
untoward
effects
was
multiorgan-
and
(5)
in part,
and
also
of such challenges,
providing
bicarbonate
Furthermore,
glutamine
might
also in-
arginine
potentially
find
associated
by susceptibility
generating
availability
to
immune
is
concentration
those
turnover
in muscle (4),
stores. Thus, given the
in supporting
cellular
surprising
athletes
(2).
role in supporting
renal
is the major
metabolic
to be dependent,
in
so
acid
on glutamine
Glutamine
as the
demands
amino
especially
an essential
appears
to determine
the rate of protein
the major repository
of mobile nitrogen
fundamental
roles played
by glutamine
and
growth
as a nonessential
confer
these conditions
(3).
bicarbonate
production
fuel
to meet
is classified
serial
study
might increase
this would be
containing
(Sigma,
with
intervals:
alkaline
decrease
after
two
0800-1
L-glutamine
of this
concentration.
aged
and juice)
designed
release
(11). After
(t = 0), either vehicle
period
Introduction
fluid
of the known
mone
coffee,
hormone
purpose
hormone
volunteers
because
sample
bicarbonate,
the body
were
pH
KEY
to increase
Nine
at 90
the
sufficient
administration
oral
Accordingly,
whether
plasma
drink
and circulating
elevated.
These
small
(8,9).
control
alkaline
reserves
as well
J Clin Nutr 1995;61:1058-61.
secretion
determine
circulating
glu-
in a cola
compared
glutamine
a surprisingly
of elevating
A,n
hormone
to the
to
plasma
both plasma
bicarbonate
concentration
growth
hormone
concentration
were
demonstrate
on
45 mm after
were obtained
returning
after
administered
dissolved
for 90 mm
before
was
effect
growth
were
controls
obtained
I wk earlier.
to the oral glutamine
load with
at 30
load
the
1995;61:1058-61.
Education
Quality
reprint
requests
State
University
Support
State
Corporation
Fund
College,
October
31,
Technology
Coland the
RD-A-IS.
to TC Welbourne,
Medical
University
Department
P0
Box
of Physiology,
33932,
Shreveport,
71130.
Received
June
Accepted
for
Printed
24,
1994.
publication
in USA.
1995
American
1994.
Society
for Clinical
Nutrition
and
fast.
glutamine
to determine
bicarbonate,
trations.
acids
after
C Welbourne
ABSTRACT
nine healthy
crease
hormone
GLUTAMINE,
TABLE
AND
Summary
GROWTH
as shown
of subject
Subject
characteristics
code
and glutamine
Age
Sex
dose
BMI
Glutamine
kg/rn2
BICARBONATE,
dose
zg/kg both
HORMONE
1. The increase
in Figure
with
the time
mm,
with
control
a gradual
initial
glutamine
50
23.5
28
vs 744 36 moVL,
64
26.4
21
60 mm after
35
21.5
29
44
35.0
18
40
23.2
25
42
26.6
27
load
36
26.25
32
38.55
16
did
37
22.32
36
show
, ii
43.5
8: subject
25.6
3.4
H not included
30
produced
1.5
in population
not
The
27 2
effect
hormone
means.
of 2.7
the
of
the
of concentrations
Kit,
acids
were
(hexokinase
Boehringer
Statistical
90
(ANOVA;
p.g/L
Glucose
using
(catalog
and
#40-2205;
nonesterified
determined
by
enzymatic
Mannheim,
assay,
Sigma,
and colorimetric
Mannheim,
Germany).
commercially
fatty
available
oral
kits
assay,
repeated
differences
test.
Where
one-tailed
measurements).
were
growth
by using
changes
was
used,
hormone;
were
otherwise
a priori,
carbon
a two-tailed
plasma
growth
control,
growth
0.029
0.015
plasma
was
hormone
subjects
showed
concentration
value
P
(0.084
0.09
by paired
a discernible
and
respectively,
peak
0.020
with
discern-
in only three of
treatment
the
4.3-fold
higher
0.04
compared
t test);
seven
at this
time.
than
with
of the
In fact,
Students
predicted
total
on
0 and 90 mm,
not
were
load
did
time
a paired
ie, glutamine,
glutamine
also
concentration.
apparent
glutamine
growth
433
30 or
at 0, 30,
variance
Between-treatment
analyzed
directional
t test
time,
of
increase,
bicarbonate
eight
in plasma
glutamine
and glucose
with
mm,
were
analyzed
by analysis
point
and
as 0.1
Institute).
a,ialysi.s
Changes
and
60,
as low
Nichols
subjects,
at either
t test
dioxide,
was
Time Control
used.
GIN
30
Results
Eight
responded
receiving
in systemic
the
oral
plasma
glutamine
load
concentration
28
. L-G(utamine
26
-J
0 Vehicle
-I
0.9
E
w
24
DS
0.8
E
0
(D
0
I
06
#{149}
0.5
Q_
0.4
30
60
90
Minutes
FIGURE
ingestion
control.
sampling
vehicle
test).
both
1. Peripheral
plasma
(2 g).
SEM;
Glutamine
was
at 30-mm
consumed
intervals.
at 30 and 60 mm,
Changes
vehicle
glutamine
in glutamine
and L-glutamine
concentrations
n = 8 subjects
over
Significant
0.01
<
20 mm,
and P
0.01,
with
difference
concentration
(P
compared
0-20
between
0.02,
with
ANOVA).
time
after
glutamine
their
own
mm
90
90
Mm
Mm
and
(paired
significant
serial
glutamine
respectively
were
with
time
a
for
FIGURE
either
vehicle
Time
averages
2.
Plasma
(time
from
bicarbonate
control)
eight
concentration
or L-glutamine
subjects
(0)
(GLN)
(subject
before
and 9() mm
after
(2 g for n = 9 subjects).
H not
included).
HGH
an increase
glutamine
plasma
in Figure
hormone
concentrations
0.002
nmol/L
at t =
ment
H had a lower
eight
0.7 mmolfL
compared
with -0.7
control,
P < 0.02. Subject
H, who
plasma
in his
is shown
subject
at 60
different
load.
exhibit
12%
significantly
load increased
the plasma
bicarbonate
in Figure
2. After 90 mm, the glutamine
a gain
an increase
it was
the other
glutamine
as seen
0.6 mmol/L
not
at 90 mm. In contrast,
than
19% compared
sustained,
to a value
the glutamine
The oral
concentration
:!: SEM
return
was prompt,
and
concentration
at 30 mm,
ttt
1059
1060
WELBOURNE
8.0
.30
Time Control
. L-Glutamine
7.5
0 Vehicle
-J
-
.20
6.5
E
jo.0
.10
8
5.5
(D
5.0
-J
4.5
4.0
C
-.9
0.05
0)
30
90
60
Minutes
FIGURE
0
0.04
ingestion
.C
both
0.03
example,
mm
0.02
____________
0
90
Mm
Plasma
vehicle
Average
growth
(time
for
hormone
control)
concentration
or L-glutamine
this
____________
0
90
Mm
subjects).
before
(GLN)
and 90 mm
(2 g for
(#{149})(subject H not
n =
included).
and
respond
60
mm,
respectively.
In
to the glutamine
concentration
mm (0% and
load
The
forearm
seen
in
glucose
venous
in Figure
mrnol/L,
forearm
subject
plasma
H did
growth
ingestion
occurs
at 30 mm as shown
occurred
blood
was
5. A greater
was observed
the time control
P
the
however,
increased
19%
this
plasma
observed
at 30
load
provoked
obese
not
glutamine
individual.
clearance
an
with
activation
of
consistent
Nevertheless,
the
present
study
clearly
ability
to
increase
plasma
bicarbonate
concentration
and
hormone
in
both
time
despite
a
in Figure
control
and
groups, reflecting
the glucose content of the vehicle.
with glucose,
the free fatty acid concentration
in
concentration
pared
with
study;
higher
with
at, or below,
the time control
value
at 30 and 60
-28%,
respectively).
Note that the rise in plasma
rise
glutamine
In contrast
contrast,
with
growth
hormone
after glutamine
small increase
in plasma glucose
4.
20 times
for
(ANOVA).
shows
that an oral glutamine
load approximating
the dose
range shown here appears to attain a window
of effectiveness
in achieving
the desired objectives
without
calling into play the
formidable,
and even counterproductive,
hepatic
mechanism
for responding
to a large increase
in plasma
glutamine
(1).
The effectiveness
of an oral glutamine
load would depend on
its
both subjects
C and F exhibited
early peak responses
that
averaged
increases
of 67% and 78% above their time control at
30
present
load
compared
0.01
<
and glutamine
was significant
hepatic glutamine
removal
(16). On the other hand, smaller oral
loads,
1 g, run the risk of being
unable
to significantly
elevate
circulating
plasma
glutamine.
The failure
to elicit a
response
in subject
H might well reflect
the limiting
dose in
3.
in the
(12)
glutamine,
vehicle
glucose
Gi
B
H
either
214%
plus
after
in plasma
accelerated
FIGURE
a glutamine
concentration
Elevation
0.01
and vehicle
glutamine
after
vehicle
glucose
subjects.
0.08,
free fatty
paired
acid
affected
by
the
glutamine
utilization
test)
the
30-60-mm
0.10 vs
consistent
(14).
free
load
fatty
as
acid
period
corn-0.10
0.04
with
enhanced
-I
U-
LU
0
E
E
ci)
0)
C
0
-C
Discussion
A surprisingly
small oral glutarnine
load, 2 g, was able to
produce
a prompt and sustained
(0.5 h) elevation
in circulating
plasma
glutamine,
indicating
that significant
amounts
of an
orally
administered
glutamine
load did reach the periphery
(15). Larger glutamine
loads would increase
plasma glutamine
even further but carry the risk of activating
hepatic uptake.
For
0-30
FIGURE
5. Glutamine
free
fatty
acid
fied
fatty
acids.
concentration
Mm
Mm
30-60
ingestion
compared
accelerates
with
60-90
the decrease
vehicle.
NEFA,
Mm
in forearm
nonesteri-
0
0
4. Plasma
for eight
GLUTAMINE,
precursor
in plasma
drive
for renal
bicarbonate
up muscle
ing
protein
base
and
generation
(1).
oral glutamine
cellular
glutamine
breakdown
(4),
also
associated
above
trols.
the low
Because
time
and
with
after
an increase
intake
(17),
(10)
the
peaks
are defined
more than
in growth
exceeded
represents
that
note
effective
Indeed,
in the time
fluctuates
conditions
were
increments,
How
an
the
smaller
secretion
However,
glutamine
was
not
growth
hormone
might
in shifting
in
(23),
(9).
utilization
exercise
Note
creases
pressed
that
a stimulus
release
to fatty
proposed
Growth
ering
plasma
increases
which
when
by acid
circulating
growth
alkaline
shown
I thank
(ammonium
homeostasis.
a potential
benefit
Sudhir
for technical
concentration
small
in terms
mix
oral
suplow-
renal
18.
20.
idosis.
JPEN
2. Rose WC.
metabolism
during
1990;l4:775-855.
Amino
acid
requirements
Fed Proc
1949;8:546-52.
stimulates
somatostatin
186-9.
2nd
ed.
New
York:
DE,
N. The
GA,
Bain
population:
RP.
relation
to
effect
of glutamine
in normal
subjects
adminisand patients
1972;51:1852-60.
Growth
hormone
accelerates
tubular
acid
1991;260:R1036-42.
GA,
Zierler
and adipose
Invest
G, Fleming
1981;67:1361-9.
Invest
Klassen
KL.
tissue
Effect
of
metabolism
human
growth
in the forearm
of
1965;44:51-61.
Marano
MA,
Campbell
and glutamic
M,
acids
McKellar
glutamine
uptake
RG.
Splanchnic
in humans.
Reach
D, Channon
Am
bed utilization
J Physiol
1993;264:
of
JOL,
ac-
26.
Johnson
endogenous
glu-
Goodship
Ammonium
and amino
acid
1992;263:E735-9.
ML.
Minimizing
J, George
J Physiol
K, et al. Marked
on day-to-day
and healthy
THJ.
breakdown
fuel
untreated
false-positive
er-
1985;248:E475-81.
effects
of sustained
metabolism:
subjects.
studies
I Clin
in
Endocri-
1993;77:1589-96.
BC,
of potent
Rational
design
receptor.
Windmueller
Science
HG,
Spaeth
HG,
I Physiol
Fukunaga
R, Nagata
antagonists
5, Golddel
DV,
to the human
Wells
growth
hor-
1992;256:1677-80.
by the small
Windmueller
AE.
Uptake
and
intestine.
J Biol
Chem
Spaeth
AE.
Source
metabolism
of
plasma
1974;249:5070-9.
citrulline.
1981;241:E473-80.
Costill
DL,
balance
during
I Sports
Med
Verstappen
H, Janssen
of exercise:
exercise.
JR. Jones
alterations
bouts
E, Fink
influence
W. Acid-base
of bicarbonate.
Int
1984;5:228-31.
balance
cycle
F, Kuipers
repeated
SE, Kraemer
50:241-7.
CM,
Am
JA.
Sutton
in
hepatic
1987;252:E746-50.
spares
detection.
levels
patients
Metab
Am
24.
Moller
hormone
glutamine
23.
AD,
pulse
J Physiol
protein
I Physiol
Fuh G, Cunningham
mone
22.
increases
Rogol
interaction
in modulating
1994;18:243-7.
Scringeour
JD,
in hormonal
JPEN
Am
Gut-liver
glutamine
SM,
Veldhuis
TC.
ammonia
Am
S. Enteral
acidosis
in humans.
growth
Welbourne
acidosis.
oxidation
nol
21.
may
Joshi
in chronic
Jorgensen
D,
role of portal
and metabolism.
TC,
tamine
base
of man.
D,
Lubin
excretion
MI.
I Physiol
homeostasis:
low
assistance.
glutamine
of the
on isolated
K. Arginine
in the adult
M, Bank
I Clin
glutamine
intensity
S. Interorgan
Am
J Clin
acid-base
Joshi
E. A
and cells
endogenous
1988;67:1
CM,
Invest
Cronin
on muscle
25. Gordon
TC,
Newsholme
brain,
endocrinolgoy.
secretion
ammonium
TC,
Rabinowitz
rors
References
1. Welbourne
hepatic
1993;4:236-42.
N,
muscle,
J, von Werder
Rogers
Weber
chloride-induced
fat oxidation
composition.
supports
1990;11:3121-7.
Metab
MH,
disease.
Welbourne
of glutamine
glutamine
substitution
favoring
neutrophils.
of n-methyl-D,L-aspartate
medical
J Clin
TC,
15. Matthews
(26),
that
patient
Biochem
by suppressing
hormone
on urinary
GH-deficient
the plasma
responses
of body
growth
man.
19.
in acid-base
both
In addition,
fuel
D, Kutner
hormone
inbe
muscle.
1992;131:1903-7.
Endocrinol
Rudman
Welbourne
Med
Schopol
Basic
Impaired
secretion.
chloride)
hormone
in elevating
hormone
hormone-dependent
Joshi
loading
for growth
growth
performance
response
can
(25). Interestingly,
a surprisingly
and
to acid-base
the growth
this
Inhibition
1994.
17. Welboume
a major
acceler-
concentration
OL,
I Nutr
skeletal
L. Effect
secretion
HM.
Press,
with
in muscle
elimination
role during
limit
hormone
hormone
a role
to be effective
reserves
contribute
suggests
with
In summary,
was
may
growth
bicarbonate
homeostasis.
load
acidogenesis
exercise
and
administration
is consistent
facilitates
important
glutamine
Endocrinology
J Clin
16. Buttrose
acids
Mi.
on phagocytosis
K. Enteral
E, McAndrew
between
Int J Sports
J, Miller
Raven
14.
amino
rat skeletal
burn
Blomstrand
link
hormone
secretion.
13.
Rennie
ofglutamine
inflammation.
P, Ohlsson
10. Goodman
hormone
to play
hormone
PW,
in perfused
and pediatric
A, Horton
during
system.
growth
11.
essential
E848-54.
load.
glucose
recently
(13).
King
M,
9. Alba-Roth
hormone
role of growth
B, Watt
by normal
rat somatotrophs.
of glu-
growth
TC,
efflux
8. Lindstrom
tration
for
K, Weryk
by glutamine
killing
7. Parry-Billings
12.
conver(22) sup-
a conditionally
1988;257:133-6.
glutathione
that
stimulus
Smith
for directly
activating
(8). Thus,
either
one or
glutamine
from
circulating
in strenuous
by bicarbonate
be
Is glutamine
1994;18:128-33.
immune
rise
and
fluxes
Lett
6. Welboume
study.
conversion
acid
PA,
breakdown
and bacterial
larger
present
known
In addition,
to an oral
growth
hormone
was
in acid-base
homeostasis
strenuous
the
amino
to the better-recognized
fuel
be
DW.
1990;48:299-309.
communicational
20%
may
would
in response
In addition
(14),
role
to
study
the
subjects
secretion.
For example,
in the small
intestine
synthesis
secretion
effectors
secretion
selected
increments
secondary
tamine
to glutamate
provides
somatotrophic
growth
hormone
both
conwith
as being
than
elucidated
initiates
arginine
MacLennan
JPEN
exert
autoinhibiting
effects
(21).
load might
stimulate
basal
growth
could
affect
growth
hormone
sion of glutamine
to citrulline
renal
ligand
activation
which
could
oral glutamine
hormone
ports
criteria
Rev
of age-dependent
conditions,
signifi-
in receptor
4.
Wilmore
NL,
the
growth
J AppI
Toews
Lynch
Physiol
Ci.
JM,
hormone
Knuttgen
response
HG.
Effect
to acute
of
high-
1994;76:821-9.
Growth
exercise.
hormone
Clin
secretion
Sci
Mol
in acidMed
1976;
(20).
more
Nutr
hormone
the time
control
value
by fourfold.
Although
this
a small
increment
in circulating
growth
hormone,
it is effective
in eliciting
growth
hormones
metabolic
effects
JM,
acid?
1061
HORMONE
of protein
load
growth
observed
concentration
the
nadir
occurred
3. Lacey
acido-
glutamine
in plasma
by the threshold
a preceding
hormone
slow-
under
oral
provide
a minimal
secretion
in a population
low secreters
(1 1). Under such controlled
cant
thereby
accelerated
GROWTH
FEBS
basal
concentrations
growth
hormone
food
AND
content
a process
genic
conditions
(17,18).
The rise in plasma
glutamine
was
BICARBONATE,